Alimta
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
On August 19, 2004, pemetrexed for injection (Alimta); Eli Lilly and Company, Indianapolis, IN, http://www.lilly.com) received…
Pemetrexed (ALIMTA, LY231514, MTA) is a novel antimetabolite that inhibits at least three enzymes involved in the folate pathway…
The purpose of this report is to summarize information on pemetrexed (LY231514; MTA; Alimta; Eli Lilly and Company; Indianapolis…
The underpinning conceptual model for the Lung Cancer Symptom Scale (LCSS), an instrument used to assess health‐related quality…
BACKGROUND
The purpose of this study was to evaluate ALIMTA (pemetrexed disodium, LY231514), a multi-targeted antifolate with…
Pemetrexed (Alimta®) is a novel, multitargeted antifolate that inhibits at least three of the enzymes involved in folate…
The purpose of this study was to identify predictive factors for severe toxicity caused by antifolate-chemotherapy using…
BACKGROUND
To evaluate the efficacy and safety of pemetrexed therapy for chemotherapy-naïve patients with surgically incurable…
BACKGROUND
To evaluate the activity of MTA plus cisplatin in chemotherapy-naive patients with non-small cell lung cancer (NSCLC…